SLXP

Salix Pharmaceuticals, Ltd. News Headlines

$133.29
*  
3.98
2.9%
Get SLXP Alerts
*Delayed - data as of Jul. 9, 2014  -  Find a broker to begin trading SLXP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SLXP Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Idenix Pharma Initiates Phase II Study - Analyst Blog
5/31/2013 6:30:14 PM - Zacks.com

GSK/Genmab Report Positive Arzerra Data - Analyst Blog
5/31/2013 6:29:25 PM - Zacks.com

Postive Interim Data on Pacira's Exparel - Analyst Blog
5/31/2013 4:27:08 PM - Zacks.com

Glaxo's Oncology Portfolio Gets a Boost - Analyst Blog
5/30/2013 7:27:26 PM - Zacks.com

ANAC's Discussion with FDA for Tavaborole - Analyst Blog
5/30/2013 5:25:48 PM - Zacks.com

Setback for Valeant Pharma - Analyst Blog
5/29/2013 6:29:48 PM - Zacks.com

Dutch Approval for Astellas' Vesomni - Analyst Blog
5/29/2013 6:28:32 PM - Zacks.com

AstraZeneca to Buy Omthera Pharma - Analyst Blog
5/29/2013 6:25:45 PM - Zacks.com

Encouraging Data from Novartis - Analyst Blog
5/29/2013 4:31:38 PM - Zacks.com

Positive Data on Salix's Budesonide Foam - Analyst Blog
5/29/2013 4:29:17 PM - Zacks.com

Encouraging Data from Novartis - Analyst Blog
5/29/2013 12:25:59 PM - Zacks.com

Valeant Pharma to Buy Bausch+Lomb - Analyst Blog
5/28/2013 8:26:27 PM - Zacks.com

Mixed News on Merck's Pipeline - Analyst Blog
5/28/2013 6:29:12 PM - Zacks.com

J&J's Promising Pharma Pipeline - Analyst Blog
5/28/2013 5:29:06 PM - Zacks.com

Obesity Data on Novo Nordisk's Victoza - Analyst Blog
5/28/2013 4:28:14 PM - Zacks.com

Positive Data from Synergy Pharma - Analyst Blog
5/24/2013 12:29:19 PM - Zacks.com

New Diagnostic Solution from Roche - Analyst Blog
5/24/2013 11:25:35 AM - Zacks.com

Pfizer Halts Inotuzumab Study - Analyst Blog
5/23/2013 7:27:11 PM - Zacks.com

Repros to Conduct Phase IIb Trial - Analyst Blog
5/23/2013 6:30:20 PM - Zacks.com

Data on AstraZeneca's Naloxegol - Analyst Blog
5/23/2013 6:28:59 PM - Zacks.com

Positive Data on Roche Candidate - Analyst Blog
5/22/2013 6:28:42 PM - Zacks.com

Data on UCB's Neupro - Analyst Blog
5/22/2013 5:27:01 PM - Zacks.com

Data on Merck KGaA's L-BLP25 - Analyst Blog
5/22/2013 5:26:38 PM - Zacks.com

AbbVie Extends Galapagos Deal - Analyst Blog
5/22/2013 11:27:43 AM - Zacks.com

Positive Data on Novo Nordisk's N9-GP - Analyst Blog
5/21/2013 5:27:42 PM - Zacks.com